Abstract
The expression of proteins involved in glucose transport in slow-twitch muscle remains almost unaltered after HFD intervention, whereas a significant decline of these proteins was observed in fast-twitch muscle. Specific activation of the UPRmt in slow-twitch muscle, accompanied by higher mitochondrial respiratory function and MOTS-c expression, may contribute to the higher resistance to HFD in slow-twitch muscle. Notably, the different histone modifications of UPRmt regulators may underlie the specific activation of the UPRmt in different muscle types. However, future work applying genetic or pharmacological approaches should further uncover the relationship between the UPRmt and insulin resistance.
Introduction: The Muscle Mosaic and Insulin Resistance
Skeletal muscle is the body's primary site for glucose disposal, making it a central player in the development of Type 2 diabetes and insulin resistance (IR). However, skeletal muscle is not a uniform tissue; it is a mosaic of different fiber types. "Slow-twitch" fibers (Type I) are oxidative and endurance-oriented, while "fast-twitch" fibers (Type II) are glycolytic and built for power.
Researchers have long observed that slow-twitch muscles are more "protected" against insulin resistance caused by high-fat diets (HFD) compared to fast-twitch muscles. This study investigates whether the mitochondrial unfolded protein response (UPRmt)—a quality-control pathway that repairs or removes damaged mitochondrial proteins—is the mechanism allowing slow-twitch muscles to maintain metabolic health under dietary stress.
Methodology: Investigating the Metabolic Divide
The study utilized a male Wistar rat model, comparing a control group to an 18-week HFD group. Researchers focused on the soleus (Sol), enriched with slow-twitch fibers, and the tibialis anterior (TA), enriched with fast-twitch fibers.
The experimental design included:
- Metabolic Testing: Hyperinsulinemic-euglycemic clamps and oral glucose tolerance tests (OGTT) to confirm systemic insulin resistance.
- Mitochondrial Respiration: Measurement of oxygen consumption and efficiency in isolated mitochondria using an Oroboros Oxygraph-2k.
- Molecular Signaling: Tracking glucose transporters (Glut4), UPRmt markers (ATF5, HSP60, ClpP), and the mitokine MOTS-c via Western blotting and qPCR.
- Epigenetics: Chromatin Immunoprecipitation (ChIP) to examine histone methylation (H3K4me3 and H3K27me3) at the Atf5 gene promoter, the master regulator of the UPRmt.
Key Insights: The UPRmt and Epigenetic Control
The study revealed several critical findings regarding muscle-specific responses to metabolic stress:
- Muscle-Type Specific UPRmt: Under HFD conditions, the UPRmt is robustly activated in slow-twitch muscle but remains largely dormant or insufficient in fast-twitch muscle.
- The Epigenetic "Switch": The Atf5 gene is regulated differently at the chromatin level. In slow-twitch muscle, HFD increases H3K4me3 (an activating mark) at the Atf5 promoter. In fast-twitch muscle, an increase in H3K27me3 (an inhibitory mark) effectively silences this protective response.
- MOTS-c as a Metabolic Messenger: MOTS-c, a peptide encoded by the mitochondrial genome, increased in slow-twitch muscle but decreased in fast-twitch muscle following HFD, suggesting its role as a "mitokine" that helps maintain local glucose transport.
- Preservation of Mitochondrial Function: Active UPRmt in the soleus maintained mitochondrial respiratory control rates (RCR), whereas TA mitochondria became inefficient, leading to a breakdown in Glut4-dependent glucose transport.
Key Results: Systemic Resistance vs. Local Resilience
After 18 weeks of a high-fat diet, the rats exhibited clear systemic insulin resistance. This was evidenced by higher HOMA-IR scores and significantly elevated blood glucose levels during oral glucose tolerance testing.
Despite this systemic resistance, the impact on local muscle tissue was highly divergent:
- Glut4 expression and glucose transport signaling only declined significantly in the fast-twitch TA muscle.
- UPRmt markers (ATF5, HSP60, and ClpP) were significantly higher in the slow-twitch Sol muscle compared to the TA under HFD conditions.
- Mitochondrial State 3 respiration and the RCR were maintained in the Sol but significantly decreased in the TA.
- Epigenetic Divergence: ChIP assays confirmed that the enrichment of the activating mark H3K4me3 at the Atf5 promoter was 0.5-fold higher in the Sol of HFD rats, while the inhibitory mark H3K27me3 was 0.77-fold higher in the TA.
Conclusion and Future Directions
While this study establishes a strong correlation between UPRmt activation and protection against insulin resistance, it remains primarily descriptive. Future research should focus on causal validation through genetic tools (e.g., CRISPR or RNAi) to determine if UPRmt activation is the definitive cause of HFD resistance.
Additionally, exploring pharmacological targets—such as UPRmt-activating drugs like nicotinamide riboside or doxycycline—could offer potential pathways to "rescue" fast-twitch muscles from insulin resistance. Translating these findings to human skeletal muscle patterns could lead to novel therapeutic strategies for Type 2 diabetes.
Summary updated